1 |
Wang, Y., V. N. Ngo, M. Marani, Y. Yang, G, Wright, L. M. Staudt, and J. Downward. 2010. Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene 29, 4658-4670.
DOI
|
2 |
Wang, Z., Y. Li, D. Kong, and F. H. Sarkar. 2010. The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness. Curr. Drug Targets 11, 745-751.
DOI
|
3 |
Wietrzyk, J., B. Filip, M. Milczarek, D. Klopotowska, M. Maciejewska, K. Dabrowska, A. Kurzepa, S. Dzimira, J. Madej, and A. Kutner. 2008. The influence of 1,25-dihydroxyvitamin D3 and 1,24-dihydroxyvitamin D3 on alphavbeta3 integrin expression in cancer cell lines. Oncol. Rep. 20, 941-952.
|
4 |
Yang, J. and Y. Liu. 2001. Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis. Am. J. Pathol. 159, 1465-1475.
DOI
|
5 |
Yan, W., Y. Fu, D. Tian, J. Liao, M. Liu, B. Wang, L. Xia, Q. Zhu, and M. Luo. 2009. PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 382, 631-636.
DOI
|
6 |
Yoon, S. O., S. Shin, and A. M. Mercurio. 2005. Hypoxia stimulates carcinoma invasion by stabilizing microtubules and promoting the Rab11 trafficking of the alpha6beta4 integrin. Cancer Res. 65, 2761-2769.
DOI
|
7 |
Zhang, L. and R. P. Hill. 2007. Hypoxia enhances metastatic efficiency in HT1080 fibrosarcoma cells by increasing cell survival in lungs, not cell adhesion and invasion. Cancer Res. 67, 7789-7797.
DOI
|
8 |
Milani, M. and A. L. Harris. 2008. Targeting tumour hypoxia in breast cancer. Eur. J. Cancer 44, 2766-2773.
DOI
|
9 |
Munoz-najar, U. M., K. M. Neurath, F. Vumbaca, and K. P. Claffey. 2006. Hypoxia stimulates breast carcinoma cell invasion through MT1-MMP and MMP-2 activation. Oncogene 25, 2379-2392.
DOI
|
10 |
Rohwer, N., M. Welzel, K. Daskalow, D. Pfander, B. Wiedenmann, K. Detjen, and T. Cramer. 2008. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. Cancer Res. 68, 10113-10120.
DOI
|
11 |
Ryu, M. H., H. M. Park, J. Chung, C. H. Lee, and H. R. Park. 2010. Hypoxia-inducible factor-1alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin. Biochem. Biophys. Res. Commun. 393, 11-15.
DOI
|
12 |
Sloan, E. K., N. Pouliot, K. L. Stanley, J. Chia, J. M. Moseley, D. K. Hards, and R. L. Anderson. 2006. Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone. Breast Cancer Res. 8, R20.
DOI
|
13 |
Song, G., Q. F. Cai, Y. B. Mao, Y. L. Ming, S. D. Bao, and G. L. Ouyang. 2008. Osteopontin promotes ovarian cancer progression and cell survival and increases HIF-1alpha expression through the PI3-K/Akt pathway. Cancer Sci. 99, 1901-1907.
|
14 |
Stemmer, V., B. De Craene, G. Berx, and J. Behrens. 2008. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene 27, 5075-5080.
DOI
|
15 |
Strutz, F., H. Okada, C. W. Lo, T. Danoff, R. L. Carone, J. E. Tomaszewski, and E. G. Nelson. 1995. Identification and characterization of a fibroblast marker: FSP1. J. Cell Biol. 130, 393-405.
DOI
|
16 |
Finger, E. C. and A. J. Giaccia. 2010. Hypoxia, inflammation, and the tumor microenvironment in metastatic disease. Cancer Metastasis Rev. 29, 285-293.
DOI
|
17 |
Vuoriluoto, K., H. Haugen, S. Kiviluoto, J. P. Mpindi,J. Nevo, C. Gjerdrum, C. Tiron, J. B. Lorens, and J. Ivaska. 2010. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer. Oncogene 8, Epub ahead of print.
|
18 |
Chung, J., S. Yoon, K. Datta, R. E. Bachelder, and A. M. Mercurio. 2004. Hypoxia-induced vascular endothelial growth factor transcription and protection from apoptosis are dependent on alpha6beta1 integrin in breast carcinoma cells. Cancer Res. 64, 4711-4716.
DOI
|
19 |
Corley, K. M., C. J. Taylor, and B. Lilly. 2005. Hypoxia-inducible factor 1a modulates adhesion, migration, and FAK phosphorylation in vascular smooth muscle cells. J. Cell Biochem. 96, 971-985.
DOI
|
20 |
Guan, F., L. Schaffer, K. Handa, and S. I. Hakomori. 2010. Functional role of gangliotetraosylceramide in epithelial-to-mesenchymal transition process induced by hypoxia and by TGF-{beta}. FASEB J. 24, 4889-4903.
DOI
|
21 |
Guarino, M. 2010. Src signaling in cancer invasion. J. Cell Physiol. 223, 14-26.
|
22 |
Lee, M., A. Lapham, M. Brimmell, H. Wilkinson, and G. Packharm. 2008. Inhibition of proteasomal degradation of Mcl-1 by cobalt chloride suppresses cobalt chloride-induced apoptosis in HCT116 colorectal cancer cells. Apoptosis 13, 972-982.
DOI
|
23 |
Lee, S. H., Y. J. Lee, and H. J. Han. 2011. Role of hypoxia-induced fibronectin-integrin beta1 expression in embryonic stem cell proliferation and migration: Involvement of PI3K/Akt and FAK. J. Cell Physiol. 226, 484-493.
DOI
|
24 |
Lu, X. and Y. Kang. 2010. Hypoxia and hypoxia-inducible factors (HIFs): master regulators of metastasis. Clin Cancer Res. 24, 5928-5935.
|
25 |
Benelli, R., S. Monteghirfo, R. Vene, F. Tosetti, and N. Ferrari. 2010. The chemopreventive retinoid 4HPR impairs prostate cancer cell migration and invasion by interfering with FAK/AKT/GSK3beta pathway and beta-catenin stability. Mol. Cancer 9, 142-155.
DOI
|
26 |
Mandal, M., J. N. Myers, S. M. Lippman, F. M. Johnson, M. D. Williams, S. Rayala, K. Ohshiro, D. I. Rosenthal, R. S. Weber, G. E. Gallick, and A. K. EI-Naggar. 2008. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Cancer 112, 2088-2100.
DOI
|
27 |
Ardyanto, T. D., M. Osaki, Y. Nagahama, K. Yamaga, N. Maeta, T. Tamura, and H. Ito. 2008. Down-regulation of cobalt-induced HIF-1alpha expression correlates with cell proliferation and apoptosis in human gastric carcinoma cells. Oncol. Rep. 19, 339-343.
|
28 |
Avizienyte, E., and M. C. Frame. 2005. Src and FAK signaling controls adhesion fate and the epithelial-to-mesenchymal transition. Curr. Opin. Cell Biol. 17, 542-547.
DOI
|